SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a major earnings beat and raised guidance that triggered a surge in institutional interest and multiple analyst price target upgrades. The community is actively debating whether this represents a sustainable AI-driven structural shift or an overextended bubble, with many traders watching closely for profit-taking signals.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as investors react to strong earnings guidance and a significant improvement in gross margins, signaling a potential recovery in profitability. The community is heavily focused on the stock's potential for a massive short squeeze, with many users dismissing negative sentiment as manipulation and viewing the current valuation as a prime opportunity for long-term growth.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors rally behind the potential for global commercialization and the anticipation of upcoming clinical data, creating a highly volatile environment marked by intense speculation of a short squeeze. The community is focused on the founder's recent communications regarding global expansion efforts, which many interpret as a strategic push to bypass regulatory hurdles and accelerate market entry.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors react to a recent earnings report that exceeded revenue expectations through high-margin licensing deals, even as community sentiment remains polarized over executive compensation and the company's long-term commercial strategy. The discourse is heavily focused on whether management's push for new equity-based incentives is justified given the stock's historical performance, while active discussions highlight potential breakthroughs in pipeline candidates and the impact of activist pressure on future corporate governance.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV remains a polarizing stock as the community debates its long-term viability amid Disney's partial stake and shifting sports media rights. While bulls highlight improving Adjusted EBITDA and potential short-squeeze opportunities from high interest, many bears point to years of consistent decline and skepticism regarding management's ability to drive profitability.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as investors weigh strong Orladeyo revenue growth against frustration over the stock's stagnant price action and the lack of updates on its pipeline assets like DME and Nethertons. The community remains heavily divided between those holding for a potential buyout or institutional accumulation and those critical of management's strategy and the high overhead of the company's employee base.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining momentum as investors eye the potential for a blockbuster valuation driven by the successful enrollment of its subcutaneous Briumvi and Azer-cel trials. The community is actively discussing bullish expectations for sustained revenue growth and the possibility of a strategic acquisition, fueled by increased institutional interest and a growing market presence for its core MS therapy.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is seeing heavy bullish sentiment driven by a major expansion of its autonomous freight network, including a deal with Hirschbach to scale its autonomous fleet. The community is actively discussing the stock's potential for a short squeeze as investors bet on the company's long-term commercialization strategy amid high institutional ownership and significant insider conviction.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors weigh strong GLP-1 volume and the rollout of its oral Wegovy pill against pricing pressure and intensifying competition, with community members actively discussing a potential rebound as the company reports earnings later this week. Discussions focus on whether the stock, which has seen a significant correction, is currently undervalued and positioned for a breakout as it captures market share in the oral medication space.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc

Ernexa Therapeutics is trending as investors react to a new cell therapy manufacturing partnership aimed at advancing its ovarian cancer candidate toward clinical trials. While community members are optimistic about potential breakthroughs in iMSC cell technology, sentiment remains sharply divided due to concerns regarding historical dilution, reverse stock splits, and the company's financial stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
